• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

Pharmalicensing Ltd
is a division of

News of the day

Industry news search

Recent news

To keep up to date with news from this category use our

Meda has settled the U.S. Astelin patent litigation with Cobalt
August 25, 2008 -- Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Cobalt Pharmaceuticals Inc. (hereafter Cobalt) that resolves the U.S. patent...

BioAlliance Pharma announces the grant of its main patent on the Lauriad
Paris, August 22, 2008 - BioAlliance Pharma SA (Euronext Paris: FR0010095596-BIO), the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, today announced the grant...

Procter & Gamble Files Infringement Lawsuit Against RNA Corporation
CINCINNATI, Aug. 21, 2008 -- The Procter & Gamble Company (NYSE: PG) has filed a lawsuit against RNA Corporation of Blue Island, Illinois, for the infringement of its Herbal Essences intellectual property, including...

Patent Issued Related to Prometheus Proprietary Test; CBir1 Antigen Test Included in Diagnostic for Inflammatory Bowel Disease
San Diego, August 21, 2008 - Prometheus Laboratories Inc. announced the issuance of U.S. Patent No. 7,361,733, "Compositions and Methods for the Therapy and Diagnosis of Inflammatory Bowel Disease" which protects a...

AorTech Issued Patent for Biostable Polyurethanes
August 21, 2008--AorTech International plc (AIM: AOR) the biomaterials and medical device development company, today announces the issue of the Australian Patent for its biostable polyurethane Elast-Eon(TM) 5 (E5). The...

AorTech Issued Patent for Biostable Polyurethanes
August 21, 2008--AorTech International plc (AIM: AOR) the biomaterials and medical device development company, today announces the issue of the Australian Patent for its biostable polyurethane Elast-Eon(TM) 5 (E5). The...

NuVasive Announces Patent Infringement Complaint Brought by Medtronic Sofamor Danek
SAN DIEGO, August 19, 2008 -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that it has obtained a...

European Patent Granted on the Application of Anti-L1 Antibodies in Cancer Therapy
Martinsried/Munich, August 19, 2008. MediGene AG (Frankfurt, Prime Standard: MDG) announces that the European Patent Office has granted a patent on the application of anti-L1 antibodies in cancer therapy. The patent (EP...

Pain Therapeutics and King Pharmaceuticals Announce Final Data of Remoxy Phase III Study at World Pain Congress in Scotland
GLASGOW, SCOTLAND - August 19, 2008 - Pain Therapeutics, Inc. (NASDAQ: PTIE) and King Pharmaceuticals, Inc. (NYSE: KG) today presented the final data set of a previously announced pivotal Phase III study of REMOXY

Urigen Announces Issuance of Key Patent for URG101 - A Novel Therapy to Treat Painful Bladder Syndrome/Interstitial Cystitis
BURLINGAME, Calif., August 19, 2008-- Urigen Pharmaceuticals, Inc. (OTC Bulletin Board: URGP, http://www.urigen.com), a specialty pharmaceutical company focused on the development and commercialization of treatments for...

Trimedyne, Inc. (TMED) Enters Into Letter of Intent With FemSuite, LLC
LAKE FOREST, CA-- August 18, 2008 - TRIMEDYNE, INC. (OTCBB: TMED) today announced it has entered into a Letter of Intent with FemSuite, LLC, a privately held company based in San Francisco which develops, manufactures...

DUSA Announces Patent Licensing Agreement
WILMINGTON, Mass. (August 14, 2008) - DUSA Pharmaceuticals, Inc.

Watson Announces District Court Ruling in Naproxen Sodium Patent Suit
CORONA, Calif., Aug. 13, 2008 -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida ruled...

WACKER and RFS Pharma Announce Assignment Agreement for an Improved Synthetic Process to Manufacture Amdoxovir
Atlanta, GA / Munich, Germany, Aug 13, 2008 -Wacker Chemie AG and RFS Pharma, LLC, announce today a successful assignment on patent applications relating to a proprietary synthesis pathway for the manufacture of RFS...

Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
LEXINGTON, Mass., August 13, 2008 -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today the issuance of U.S. Patent No. 7,410,978 (the "'978 patent"), entitled "Once Daily Dosage Forms of Trospium," which is...

HEALTH DISCOVERY CORPORATION'S NEWEST U.S. PATENT COVERS SVM-BASED ANALYSIS OF MEDICAL IMAGES
SAVANNAH, GA, Tuesday, August 12, 2008 - Health Discovery Corporation ("HDC") (OTCBB: HDVY) today announced that the United States Patent and Trademark Office has granted Patent No. 7,383,237 on HDC's claims covering...

Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges
MONTVALE, N.J., Aug. 12-- Barr Pharmaceuticals, Inc. (NYSE: BRL) announced today that its Barr Laboratories subsidiary has signed a Settlement Agreement and a License Agreement with Boehringer Ingelheim to resolve the...

I-Flow Corporation Enforcing Patent and Trade Secret Rights Against Apex Medical's SOLACE(R) Pump
LAKE FOREST, Calif., August 12, 2008 -- I-Flow Corporation (NASDAQ:IFLO) has commenced a lawsuit against Apex Medical Technologies, Inc. and its president, Mark McGlothlin, for infringing I-Flow's United States Patent...

Sense Proteomic Ltd files patent on a panel of autoantibody biomarkers for the early diagnosis and monitoring of Systemic Lupus Erythematosus
Maidenhead, UK: August 11, 2008, Sense Proteomic Ltd today announced that it has expanded its biomarker IP portfolio through filing a patent covering a novel panel of biomarkers for the early diagnosis of Systemic Lupus...

Benitec Double-Stranded Patent Granted in New Zealand
August 8, 2008, Melbourne, Australia: Benitec Limited (ASX: BLT) today announced that a key patent focused on producing Double-Stranded Nucleic Acid constructs for therapeutic and related applications of RNA...

Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
CHESHIRE, Conn., Aug 07, 2008 -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the U.S. Patent and Trademark Office has issued Patent Number 7,408,041 titled, "Polypeptides and Antibodies Derived...

Texas Court Issues Markman Ruling in Candela's Suit Against Palomar
WAYLAND, Mass.-- August 7, 2008--Candela Corporation (NASDAQ: CLZR), a global leader in the development and commercialization of advanced aesthetic laser and light-based systems, announced today that the United States...

Oxycom - New US patent for Uscom
August 7th, 2008- Uscom received its US patent no 7338447, the method for combining blood flow measurement (USCOM) with oximetry to provide a noninvasive measure of the amount of oxygen being delivered to the cells of...

Helix BioMedix Announces U.S. Patent Issuance for Novel Class of Antimicrobial
August 06, 2008 - Bothell, Washington -- Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced that it has been issued U.S. Patent number 7,407,940 by the United States Patent and...

InNexus Biotechnology Announces Third Antibody and Expands Pipeline of Anticancer Compounds
BRITISH COLUMBIA, Canada - 6 August 2008 - InNexus Biotechnology Inc. (OTCBB: IXSBF)(TSX VENTURE: IXS), (http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies...

Lipid Sciences Granted Two Fundamental Viral Immunotherapy Patents
PLEASANTON, CA, August 06, 2008 -- Lipid Sciences, Inc. (NASDAQ: LIPD) announced the issuance of two key patents covering fundamental aspects of the Company's Viral Immunotherapy platform. These two patents, 1) U.S....

ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
August 5, 2008 -- Halifax, Nova Scotia - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, today announced receipt of patent approval from the Japanese Patent Office for its vaccine platform. The...

AorTech Issued Patent for Polymer Heart Valve in Europe
August 04, 2008--AorTech International plc (AIM: AOR) the biomaterials and medical device development company, today announces the issue of the European Patent for its Polymer Heart Valve ("PHV"). The addition of this...

Alnylam Consolidates Intellectual Property for RNA Activation (RNAa), a New Biological Discovery for Activation of Gene Expression
CAMBRIDGE, Mass.--Aug. 4, 2008--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it has consolidated the key intellectual property (IP) for RNA activation (RNAa),...

Health Discovery Corporation Inks Agreement with Patent Profit International for Monetization of Patent Portfolio
August 4, 2008 -- SAVANNAH, Ga.--Health Discovery Corporation (OTCBB: HDVY), a leader in support vector machine (SVM) based molecular diagnostic and prognostic test development today announced the signing of an...

AorTech Issued Patent for Polymer Heart Valve in Europe
August 04, 2008--AorTech International plc (AIM: AOR) the biomaterials and medical device development company, today announces the issue of the European Patent for its Polymer Heart Valve ("PHV"). The addition of this...

New Long-Term Prospective Study of Statin Drugs Confirms Utility To Reduce Risk of Dementia and Memory Loss
HASBROUCK HEIGHTS, N.J. (August 1, 2008) Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer's disease (AD),...

GLOBAL BIO-CHEM PREVAILS IN INTERNATIONAL TRADE COMMISSION PATENT INFRINGEMENT INVESTIGATION
August 01, 2008 -- After two years of investigation concerning the Ajinomoto Heartland LLC and Ajinomoto Co., Inc. (Ajinomoto)'s complaint of alleged infringement of its asserted patents of certain lysine products, the...

Barr Confirms Patent Challenge of Xyzal(R), 5mg Tablets
MONTVALE, N.J., July 31, 2008-- Barr Pharmaceuticals, Inc. (NYSE: BRL) today confirmed that its subsidiaries, Barr Laboratories, Inc. and PLIVA-Hrvatska D.O.O., have initiated a challenge of the patent listed by UCB...

SonoSite And GE Resolve First Lawsuit
BOTHELL, WA - July 31, 2008 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced that the lawsuit General Electric Company (GE) filed against...

ST Receives Allowance from US Patent
London - 31 July 2008 - Silence Therapeutics plc (AIM: SLN), a leading European RNAi focused biotechnology company, today announced that the United States Patent and Trademark Office has allowed the Company's core RNAi...

Peptimmune, Inc. Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
CAMBRIDGE, Mass., July 30, 2008-- Peptimmune, Inc. a privately held biotechnology company, announced today the grant of US Patent Number 7,381,790 (the '790 patent) which protects the composition of matter for its...

Settlement of Homocysteine Litigation
Dundee, Scotland, 30 July 2008: Axis-Shield plc (LSE:ASD, OSE:ASD), the international in vitro diagnostics company, today announces that it has entered into an agreement with Diazyme Laboratories, a division of General...

DuPont Settles with Cortron on Cyrel® FAST Thermal Platemaking Patent Technology
Wilmington, Del., July 30, 2008 - DuPont today announced it has reached an agreement with Cortron Corporation to settle a patent infringement case involving DuPont's award-winning DuPont(TM) Cyrel® FAST thermal...

NuGEN Receives Patent for Global Nucleic Acid Amplification
San Carlos, Calif.--July 30, 2008-- NuGEN Technologies, Inc., a privately held company that develops and commercializes nucleic acid amplification and labeling systems announced today that it has received US Patent No....

Gene Bridges granted Patents in Japan and Mexico for Recombineering Technology
Heidelberg, July 30, 2008 - Gene Bridges GmbH, the recombineering company, announced that it has been granted patents in Japan and in Mexico relating to the Company's recombineering technology. The Japanese Patent (No....

Court Rules in Favor of Bard on Patent Infringement Suit against W. L. Gore & Associates
MURRAY HILL, N.J., Jul 30, 2008 -- C. R. Bard, Inc. (NYSE: BCR) today announced that a U.S. District Court in Arizona entered judgment in Bard's favor in its patent infringement suit against W. L. Gore & Associates. The...

OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003
SAN DIEGO, July 29, 2008 -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX) today announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a patent application that would...

Barr Confirms Patent Challenge of Sensipar(R) Tablets, 30mg, 60mg and 90mg
MONTVALE, N.J., July 29-- Barr Pharmaceuticals, Inc. (NYSE: BRL) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Amgen Inc. in connection with its...

Epigenomics AG Receives Allowance for Key Patent in Europe
July 29, 2008 -- Berlin, Germany, and Seattle, WA, USA, -- Epigenomics AG (Frankfurt Prime Standard: ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer...

NVENTA WINS EUROPEAN PATENT CHALLENGE COVERING LEAD PRODUCT CANDIDATE HSPE7 AND OTHER HPV THERAPEUTICS
July 29, 2008 -- San Diego, California USA - Nventa Biopharmaceuticals Corporation (TSX:NVN) announced today that it has received a favorable decision from the Technical Board of Appeal of the European Patent Office...

Biotest AG: Biotest awarded patent protection in the USA
Dreieich, 29 July 2008. Biotest's BT-061 monoclonal antibody has been recognised as an innovative development and awarded comprehensive patent protection in the USA. Accordingly, a notice of allowance has been issued to...

Lorus Therapeutics Announces Allowance of New United States Patent for its Anticancer Drug LOR-2040
TORONTO, CANADA, JULY 29, 2008 - Lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus"), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the...

CYTOMEDIX RETAINS DR. DAVID F. COUNTS, INVENTOR OF COMPANY'S ANTI-INFLAMMATORY PEPTIDE PATENT
Rockville, MD, July 28, 2008 - Cytomedix, Inc. (AMEX: GTF), today announced that David F. Counts Ph.D., a leading pharmacologist and medical researcher who discovered the Company's anti-inflammatory peptide, CT-112, has...

LANNETT COMPANY COMMENTS ON LITIGATION WITH KV PHARMACEUTICALS
Philadelphia, PA - July 25, 2008 - Lannett Company, Inc. (AMEX: LCI), a manufacturer of generic pharmaceuticals, today said that on June 06, 2008 it initiated a lawsuit against KV Pharmaceuticals, Inc. and its...

Cara Therapeutics Announces Issuance of U.S. Patent Covering Second Generation Kappa Opioid Receptor Agonists
Shelton, CT, July 22nd, 2008 --Cara Therapeutics, Inc. announced today that The United States Patent and Trademark Office has issued U.S. Patent No. 7,402,564 entitled "Synthetic Peptide Amides" under its Accelerated...

High-Affinity Antibody Technology (GANP®Mouse Technology) has been Patented by the Chinese Patent Office
July 18, 2008- We hereby announce that a high-affinity antibody technology using GANP mouse, a part of patent applications regarding "GANP®mouse technology (*1)" (hereinafter referred to as "the Technology") which is a...

Panacea Biotec receives US Patent for 'Thank God' TM
July 9, 2008 -Panacea Biotec, India's leading research based Health Management Company involved in research, manufacturing and marketing of branded pharmaceutical formulations, vaccines and natural products has been...

New Medical-Use Patent for HGF Gene Therapy Granted in USA.. Covering Treatment and Prophylaxis of Auditory Dysfunction
July 8, 2008--AnGes MG Inc. announces that a patent for the medicinal use of HGF gene for the treatment and prophylaxis of auditory dysfunction was granted in USA, and the Patent Gazette (US 7,390,482) was issued.

Phynova Announces Notification of Patent Allowance
July 8, 2008 -- Phynova (AIM: PYN), the developer of prescription pharmaceuticals derived from plants used in Chinese medicines, announces that the United States Patent and Trademark Office has issued the Company a...

New Medical Use Patent for HGF Granted in Japan.. Covering the Treatment of Lymphedema
July 2, 2008--AnGes MG Inc. announces that a patent for the medicinal use of the HGF gene and HGF protein for lymphedema was granted in Japan, and the Official Gazette (JP4111993) was issued.

VNUS Medical Technologies, Inc. Files Patent Infringement Lawsuits Against Biolitec, Dornier and CoolTouch
SAN JOSE, Calif. - July 2, 2008 - VNUS® Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, announced today that it has...

Neuron BPh patents the neuroprotective and antiepileptic activity of a group of pharmaceutical products
July 01, 2008 - Neuron BPh, a company situated in the Granada Health-Science Technological Park, has recently patented the use of a well known group of pharmaceutical products for their antiepileptic properties and...

PrimeraDx Receives Issuance of Key Patent
Mansfield, MA, May 24, 2008 / -- PrimeraDx, Inc. today announced the issuance of a key patent further strengthening its position in multiplexed and quantitative nucleic acid analysis.

NIMS' Motion Platform Treatments Beneficial in Patients with Heart Failure and Peripheral Arterial Disease
December 4, 2007 -- Gary Macleod, Chief Executive Officer, Non-Invasive Monitoring Systems, Inc. [NIMS] (NIMU.OB) announced that Drs Kohler, Bloch and associates from the University Hospital of Zurich published a paper...

NIMS' Motion Platform Pre- and Post-Treatments Beneficial in Experimental Cardiac Arrest.
November 15, 2007 -- NORTH BAY VILLAGE, Fla. -- Gary Macleod, Chief Executive Officer, Non-Invasive Monitoring Systems, Inc. (NIMS) (OTCBB:NIMU) announced that Drs Jose A. Adams, Jorge Bassuk and associates from Mt....

Non-Invasive Monitoring Systems, Inc. (NIMS) Announces Patent Issued on Non-Invasive Means to Treat Ailments in Horses.
June 12, 2007 -- NORTH BAY VILLAGE, Fla. -- Gary Macleod, Chief Executive Officer, Non-Invasive Monitoring Systems, Inc. (OTCBB:NIMU) announced that the US Patent Office issued Patent 7,228,576 on June 12, 2007...

Non-Invasive Monitoring Systems, Inc. (NIMS) Announces European Patent Issued for its Motion Platform Technology.
April 17, 2007 -- NORTH BAY VILLAGE, Fla. -- Gary Macleod, Chief Executive Officer of Non-Invasive Monitoring Systems, Inc. (NIMS) (OTCBB:NIMU) announced that the European Patent Office issued Patent 1006845 entitled,...

Non-Invasive Monitoring Systems, Inc. (NIMS) Announces Patent on Multiple Applications for its Motion Platform Technology.
October 19, 2006 -- NORTH BAY VILLAGE, Fla. -- Gary MacLeod, Chief Executive Officer, Non-Invasive Monitoring Systems, Inc. (OTCBB:NIMU) (NIMS) announced that the US Patent Office issued Patent 7,111,346 on September...

NIMS' Modified AT-101(TM) Motion Platform Device Superior to Mechanical Closed Chest Message Device in CPR.
September 6, 2006 -- NORTH BAY VILLAGE, Fla. -- Gary Macleod, Chief Executive Officer, Non-Invasive Monitoring Systems, Inc. (OTCBB:NIMU) announced report of a research study of a modification of NIMS' flagship,...

Non-Invasive Monitoring Systems, Inc. (NIMS) Announces Grant of Patent on Non-Invasive Means to Stimulate Release of Beneficial Mediators from Inner Lining of Blood Vessels.
August 17, 2006 -- NORTH BAY VILLAGE, Fla. -- Gary MacLeod, Chief Executive Officer, Non-Invasive Monitoring Systems, Inc. (OTCBB:NIMU) announced that the US Patent Office issued Patent 7,090,648 on August 15, 2006...

Non-Invasive Monitoring Systems, Inc. Announces Effectiveness of Their Patented, Non-Invasive, Drug-Free Device in Experimental Asthma.
July 24, 2006 -- NORTH BAY VILLAGE, Fla. -- Gary Macleod, Chief Executive Officer, Non-Invasive Monitoring Systems, Inc. (OTCBB:NIMU) announced that a research study of the Company's patented, drug-free device, the...

Non Invasive Monitoring Systems, Inc. NIMS Receives Notice of Allowance from US Patent Office.
April 26, 2006 -- NORTH BAY VILLAGE, Fla. -- Gary Macleod, Chief Executive Officer, announced that, "Non-Invasive Monitoring Systems, Inc. (OTCBB:NIMU) recently received notice of allowance for a third US patent on its...

Non-Invasive Monitoring Systems, Inc. (NIMS)(NIMU.OB) Receives Notices of Patent Allowances from US and European Offices.
March 29, 2006 -- NORTH BAY VILLAGE, Fla. -- Gary Macleod, Chief Executive Officer, announced that Non-Invasive Monitoring Systems, Inc.(OTCBB:NIMU) recently received notice of allowance for a US patent on its flagship...

Industry news: Pharmalicensing provides comprehensive industry coverage.

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us